Michael Scolaro

Michael Scolaro

Oct 16, 2017

Group 6 Copy 97
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Are climate change and air pollution triggering cardiovascular disease?

    Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...

    How does taking Ritalin affect depersonalization-derealization disorder patients?

    We are investigating Ritalin's role in alleviating symptoms of depersonalization-derealization (DPDR) disorder...

    MyHealthEd

    Each child deserves quality comprehensive sexual health education. No child is the same, so why...

    Backer Badge Funded